Head-to-head · WeighScore
DreamHug Medical vs Nucific
The verdict
DreamHug Medical takes it — 57.9/100 to 56.2/100, but only just.
DreamHug Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DreamHug Medical is a direct-to-consumer telehealth weight-loss platform offering semaglutide and claiming all-50-state coverage through a large affiliated doctor network. Nucific is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | DreamHug Medical | Nucific |
|---|---|---|
| WeighScore | 57.9/100 | 56.2/100 |
| Grade | C | C |
| Scorecard rank | #386 | #417 |
| Semaglutide | $188/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $238/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #386 · C
Strengths
- Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
- 100% money-back guarantee if you're not approved
- Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
- LegitScript logo displayed
Where it loses points
- Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
- Pricing not disclosed — fully gated behind sign-up
- LegitScript ID number not shown (only the logo)
- Pharmacy partner not disclosed
- Named medical director not disclosed
Graded #417 · C
Strengths
- Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
- Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
- Discloses that featured patients were compensated for their time
- Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
- Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue
Where it loses points
- No price is published anywhere; every option is gated behind a three-minute quiz
- The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
- A BBB Accredited A+ claim is displayed without a link to the BBB profile
- No state list and no named pharmacy, only licensed U.S. pharmacies
- Before-and-after photographs are used alongside compensated testimonials
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.